Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999–2003

[1]  B. Hull,et al.  Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005. , 2007, Communicable diseases intelligence quarterly report.

[2]  J. Poolman,et al.  Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model. , 2005, Vaccine.

[3]  J. Poolman,et al.  Are vaccination programs and isolate polymorphism linked to pertussis re-emergence? , 2005, Expert review of vaccines.

[4]  F. Mooi,et al.  Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. , 2005, Microbes and infection.

[5]  F. Mooi,et al.  Analysis of Bordetella pertussis Populations in European Countries with Different Vaccination Policies , 2005, Journal of Clinical Microbiology.

[6]  K. Forsyth,et al.  Pertussis Immunization in the Global Pertussis Initiative International Region: Recommended Strategies and Implementation Considerations , 2005, The Pediatric infectious disease journal.

[7]  D. Greenberg,et al.  Health Burden of Pertussis in Infants and Children , 2005, The Pediatric infectious disease journal.

[8]  J. Caro,et al.  Potential Strategies to Reduce the Burden of Pertussis , 2005, The Pediatric infectious disease journal.

[9]  D. Greenberg,et al.  New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Y. Arakawa,et al.  Antigenic Divergence Suggested by Correlation between Antigenic Variation and Pulsed-Field Gel Electrophoresis Profiles of Bordetella pertussis Isolates in Japan , 2004, Journal of Clinical Microbiology.

[11]  B. Hull,et al.  Vaccine preventable diseases and vaccination coverage in Australia 2001 to 2002. , 2004, Communicable diseases intelligence quarterly report.

[12]  S. Lauwers,et al.  Simple Algorithm for Identification of Bordetella pertussis Pertactin Gene Variants , 2004, Journal of Clinical Microbiology.

[13]  F. Mooi,et al.  Temporal trends in circulating Bordetella pertussis strains in Australia , 2004, Epidemiology and Infection.

[14]  W. Hryniewicz,et al.  The new strategy for allele identification of the genes coding for pertussis toxin subunit S1 (ptx S1) and pertactin (prn) in Bordetella pertussis. , 2003, Journal of microbiological methods.

[15]  S. Thiberge,et al.  Comparison of the Bordetella pertussis and Bordetella parapertussis Isolates Circulating in Saint Petersburg between 1998 and 2000 with Russian Vaccine Strains , 2003, Journal of Clinical Microbiology.

[16]  S. Halperin,et al.  Pertussis of adults and infants. , 2002, The Lancet. Infectious diseases.

[17]  J. Mertsola,et al.  Rapid Typing of Bordetella pertussis Pertussis Toxin Gene Variants by LightCycler Real-Time PCR and Fluorescence Resonance Energy Transfer Hybridization Probe Melting Curve Analysis , 2002, Journal of Clinical Microbiology.

[18]  L. Irwig,et al.  Serological diagnosis of pertussis: evaluation of IgA against whole cell and specific Bordetella pertussis antigens as markers of recent infection , 2002, Epidemiology and Infection.

[19]  J. Mertsola,et al.  Rapid identification of Bordetella pertussis pertactin gene variants using LightCycler real-time polymerase chain reaction combined with melting curve analysis and gel electrophoresis. , 2001, Emerging infectious diseases.

[20]  R. George,et al.  Genotypic Variation in the Bordetella pertussis Virulence Factors Pertactin and Pertussis Toxin in Historical and Recent Clinical Isolates in the United Kingdom , 2001, Infection and Immunity.

[21]  C. Boursaux-Eude,et al.  Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines. , 2001, Vaccine.

[22]  A. Bradford.  The Australian Immunisation Handbook , 2000 .

[23]  T. Popović,et al.  Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. , 2000, The Journal of infectious diseases.

[24]  J. Amin,et al.  Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998. , 2000, Communicable diseases intelligence.

[25]  F. Mooi,et al.  Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. , 2000, Emerging infectious diseases.

[26]  F. Mooi,et al.  Epidemiological Typing of Bordetella pertussis Isolates: Recommendations for a Standard Methodology , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[27]  M. Brennan,et al.  Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  F. Mooi,et al.  Variation in the Bordetella pertussis Virulence Factors Pertussis Toxin and Pertactin in Vaccine Strains and Clinical Isolates in Finland , 1999, Infection and Immunity.

[29]  G Dunn,et al.  Statistical methods in laboratory medicine. , 1999, Statistical methods in medical research.

[30]  F. Mooi,et al.  Polymorphism in the Bordetella pertussisVirulence Factors P.69/Pertactin and Pertussis Toxin in The Netherlands: Temporal Trends and Evidence for Vaccine-Driven Evolution , 1998, Infection and Immunity.

[31]  R. Andrews,et al.  Pertussis notifications in Australia, 1991 to 1997. , 1997, Communicable diseases intelligence.

[32]  J. W. Bass,et al.  Return of epidemic pertussis in the United States. , 1994, The Pediatric infectious disease journal.

[33]  B. Meade,et al.  Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase. , 1983, The Journal of biological chemistry.

[34]  T. Katada,et al.  Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model. , 1982, Biochemistry.

[35]  M. Kirk,et al.  Australia's notifiable diseases status, 2003 annual report of the National Notifiable Diseases Surveillance System. , 2005, Communicable diseases intelligence quarterly report.

[36]  F. Mooi,et al.  Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? , 2001, Emerging infectious diseases.